Basics OmniAb, Inc. IPO Date: September 30, 2021 Sector: Healthcare Industry: Biotech Market Cap: $162.71M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 2.61% Avg Daily Range (30 D): $0.05 | 3.20% Avg Daily Range (90 D): $0.07 | 2.94% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .86M Avg Daily Volume (90 D): .68M Trade Size Avg Trade Size (Sh.): 113 Avg Trade Size (Sh.) (30 D): 170 Avg Trade Size (Sh.) (90 D): 131 Institutional Trades Total Inst.Trades: 104 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $1.27M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .45M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.62M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.92M Avg Closing Volume: 442.48K         News May 5, 2025 @ 4:59 PM VERAXA Biotech Enters Co-discovery Alliance with O... Source: N/A Apr 30, 2024 @ 9:55 PM USANA Health Sciences (USNA) Q1 Earnings and Reven... Source: Zacks Equity Research Mar 26, 2024 @ 12:40 PM Over $1M Bet On OmniAb? Check Out These 3 Stocks I... Source: Avi Kapoor Mar 5, 2024 @ 10:35 PM Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Rev... Source: Zacks Equity Research Feb 29, 2024 @ 1:40 PM Karyopharm Therapeutics (KPTI) Reports Q4 Loss, To... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.17 $-.13 $-.61 Diluted EPS $-.17 $-.13 $-.61 Revenue $ 4.15M $ 10.8M $ 26.39M Gross Profit $ $ $ Net Income / Loss $ -18.2M $ -13.07M $ -62.03M Operating Income / Loss $ -18.84M $ -15.88M $ -74.5M Cost of Revenue $ $ $ Net Cash Flow $ -16.71M $ .36M $ 11.24M PE Ratio